Literature DB >> 6745188

Reduced frequency of pulsatile luteinizing hormone secretion in the luteal phase of the rhesus monkey. Involvement of endogenous opiates.

D A Van Vugt, N Y Lam, M Ferin.   

Abstract

Pulsatile secretion of LH in women has been shown to vary during the menstrual cycle. LH pulse frequency during the luteal phase is markedly reduced compared to that in the follicular phase. The objectives of the present study were to determine if similar changes in pulsatile LH secretion occur in the monkey, and whether endogenous opiates are involved in producing these changes. In order to document if LH pulse frequency is reduced in the nonhuman primate luteal phase, serial blood samples were collected from 10 rhesus monkeys at 15-min intervals for 6 h at 3 different times of the luteal phase (early, mid-, and late). This pattern of secretion was contrasted to that observed during the ensuing early follicular phase. LH pulse frequency during the luteal phase was significantly reduced compared to the early follicular phase. Mean pulse frequency (+/- SE) was 0.84 +/- 0.16 pulses/6 h in the luteal phase vs. 2.99 +/- 0.58 pulses/6 h in the early follicular phase. When endogenous opioid activity was blocked during the luteal phase by a 5-h continuous infusion of naloxone (2 mg/h), an opiate antagonist, LH pulse frequency was increased to 2.48 +/- 0.25 pulses/5 h. This frequency was markedly different from the frequency of 0.85 +/- 0.17 pulses/5 h observed in the control period which immediately preceeded the naloxone infusion. The mean amplitude of the LH pulses in the luteal phase, which was significantly greater than that observed in the early follicular phase (20.9 +/- 1.9 ng/ml and 11.7 +/- 0.3 ng/ml) was not affected by naloxone (23.5 +/- 2.4 ng/ml vs. 25.3 +/- 1.9 ng/ml). Infusion of naloxone for longer periods (9 h) in 3 additional monkeys caused an increase in LH pulse frequency which was maintained in 2 of the monkeys, whereas the third animal exhibited only an acute response (a single pulse). These results indicate that the reduction in LH pulse frequency that occurs in the luteal phase of the rhesus menstrual cycle is an event in which endogenous opiates participate. Our previous finding that beta-endorphin release from neurons in the median eminence is stimulated during the luteal phase of the monkey, together with the present results, suggest that beta-endorphin functions as a modulator of pulsatile LH secretion in the primate menstrual cycle.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6745188     DOI: 10.1210/endo-115-3-1095

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Effects of opioid receptor blockade on luteinizing hormone (LH) pulses and interpulse LH concentrations in normal women during the early phase of the menstrual cycle.

Authors:  W S Evans; J Y Weltman; M L Johnson; A Weltman; J D Veldhuis; A D Rogol
Journal:  J Endocrinol Invest       Date:  1992 Jul-Aug       Impact factor: 4.256

2.  Neurobiology of stress-induced reproductive dysfunction in female macaques.

Authors:  Cynthia L Bethea; Maria Luisa Centeno; Judy L Cameron
Journal:  Mol Neurobiol       Date:  2008-10-18       Impact factor: 5.590

3.  Evidence that the arcuate nucleus is an important site of progesterone negative feedback in the ewe.

Authors:  Robert L Goodman; Ida Holaskova; Casey C Nestor; John M Connors; Heather J Billings; Miro Valent; Michael N Lehman; Stanley M Hileman
Journal:  Endocrinology       Date:  2011-06-21       Impact factor: 4.736

4.  The hypothalamic-pituitary-luteal axis in women: effects of long-term orally active opioid antagonist (naltrexone) administration.

Authors:  A M Fulghesu; A Lanzone; R Apa; M Guido; M Ciampelli; F Cucinelli; A Caruso; S Mancuso
Journal:  J Endocrinol Invest       Date:  1997 Jul-Aug       Impact factor: 4.256

Review 5.  Evidence for a Coupled Oscillator Model of Endocrine Ultradian Rhythms.

Authors:  Azure D Grant; Kathryn Wilsterman; Benjamin L Smarr; Lance J Kriegsfeld
Journal:  J Biol Rhythms       Date:  2018-08-22       Impact factor: 3.182

6.  Unexpected responses of the hypothalamic gonadotropin-releasing hormone "pulse generator" to physiological estradiol inputs in the absence of the ovary.

Authors:  J S Kesner; R C Wilson; J M Kaufman; J Hotchkiss; Y Chen; H Yamamoto; R R Pardo; E Knobil
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

7.  Cyproheptadine treatment in Cushing's disease.

Authors:  R Tanakol; F Alagöl; H Azizlerli; O Sandalci; T Terzioğlu; F Berker
Journal:  J Endocrinol Invest       Date:  1996-04       Impact factor: 4.256

8.  The negative feedback actions of progesterone on gonadotropin-releasing hormone secretion are transduced by the classical progesterone receptor.

Authors:  D C Skinner; N P Evans; B Delaleu; R L Goodman; P Bouchard; A Caraty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

Review 9.  The effects of opioids and opioid analogs on animal and human endocrine systems.

Authors:  Cassidy Vuong; Stan H M Van Uum; Laura E O'Dell; Kabirullah Lutfy; Theodore C Friedman
Journal:  Endocr Rev       Date:  2009-11-10       Impact factor: 19.871

10.  Hypothalamic neurons preferentially respond to female nest coo stimulation: demonstration of direct acoustic stimulation of luteinizing hormone release.

Authors:  M F Cheng; J P Peng; P Johnson
Journal:  J Neurosci       Date:  1998-07-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.